Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...
Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause ...
A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...
A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...
Hello Health Rounds Readers! Today we report on a promising animal study of a mRNA vaccine that could one day prevent or ...
At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...
Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...
The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...
News Medical on MSN21h
New single-chain mRNA vaccines offer enhanced immunity and protection against mpoxStudy reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...
A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...
He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...
Dr Patrick Moore, chief investigator of the study and National Institute for Health and Care Research (NIHR) director in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback